Netherlands Pharmaceuticals

Pharming Group NV (PHARM)

Track

Pharming Group NV has seen no insider trading activity in the last three months. The most recent transaction occurred on November 26, 2025, when the Chief Medical Officer sold 90,691 shares. Prior to this, several executives executed multiple sell transactions throughout 2025. There have been no reported insider purchases since May 2024.
Ticker: PHARM Exchange: AEX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Pharming Group NV. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 26 Nov 2025
Value €2,496,131.11 | Price 101.69 | Shares 59,680
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-29 2025-11-26 S Sale
2.2
Relan A.

Chief Medical Officer

59,680
101.69
€2,496,131 		59,680 101.69 €2,496,131
2025-09-06 2025-08-29 S Sale
2.2
Relan A.

Chief Medical Officer

54,693
51.61
€2,436,840 		54,693 51.61 €2,436,840
2025-08-29 2025-08-25 S Sale
0.7
Outersterp, van R.

Chief Compliance and Ethics Officer

68,744
82.06
€4,833,180 		68,744 82.06 €4,833,180
2025-08-29 2025-08-21 S Sale
1.5
Toor S.

Chief Commerfcial Officer

23,720
1.06
€25,143 		23,720 1.06 €25,143
2025-08-29 2025-08-19 S Sale
1.5
Toor S.

Chief Commercial Officer

876,280
1.06
€928,857 		876,280 1.06 €928,857
2025-06-18 2025-06-11 S Sale
2.2
Sanders M.

Chief Operations Officer

331,899
1.02
€338,537 		331,899 1.02 €338,537
2024-08-15 2024-08-08 S Sale
1.5
Toor S.

Chief Commercial Officer

8,778
0.74
€6,496 		8,778 0.74 €6,496
2024-08-15 2024-08-07 S Sale
1.5
Toor S.

Chief Commercial Officer

178,922
0.74
€132,402 		178,922 0.74 €132,402
2024-08-09 2024-08-01 S Sale
2.2
Sanders M.

Chief Operations Officer

199,458
0.77
€153,583 		199,458 0.77 €153,583
2024-05-20 2024-05-20 S Sale
3.2
S. de Vries
Director or Supervisory Board Member
48,996
0.83
€40,667 		48,996 0.83 €40,667
2024-05-20 2024-05-20 B Purchase
3.2
S. de Vries
Director or Supervisory Board Member
98,981
0.81
€80,175 		98,981 0.81 €80,175
2022-10-27 2022-10-27 B Purchase
3.9
S. Baert
Director or Supervisory Board Member
9,760
0.94
€9,174 		9,760 0.94 €9,174
2022-10-27 2022-10-27 B Purchase
3.9
L. Kruimer
Director or Supervisory Board Member
9,760
0.94
€9,174 		9,760 0.94 €9,174
2022-10-27 2022-10-27 B Purchase
3.8
J. van der Meijs
Director or Supervisory Board Member
9,760
0.94
€9,174 		9,760 0.94 €9,174
2022-10-27 2022-10-27 B Purchase
3.3
D.A. Jorn
Director or Supervisory Board Member
9,760
0.94
€9,174 		9,760 0.94 €9,174
2022-10-27 2022-10-27 B Purchase
3.4
B. Yanni
Director or Supervisory Board Member
9,760
0.94
€9,174 		9,760 0.94 €9,174
2022-10-27 2022-10-27 B Purchase
3.4
M. Pykett
Director or Supervisory Board Member
9,760
0.94
€9,174 		9,760 0.94 €9,174
2022-08-04 2022-08-04 B Purchase
3.4
B. Yanni
Director or Supervisory Board Member
9,760
0.77
€7,515 		9,760 0.77 €7,515
2022-08-04 2022-08-04 B Purchase
3.3
D.A. Jorn
Director or Supervisory Board Member
9,760
0.77
€7,515 		9,760 0.77 €7,515
2022-08-04 2022-08-04 B Purchase
3.8
J. van der Meijs
Director or Supervisory Board Member
9,760
0.77
€7,515 		9,760 0.77 €7,515
Explore more

More insider trading research around Pharming Group NV

More insider trades in Netherlands
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe